{"cik":"0001415397","entityName":"Raphael Pharmaceutical Inc.","facts":{"dei":{"EntityCommonStockSharesOutstanding":{"label":"Entity Common Stock, Shares Outstanding","description":"Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.","units":{"shares":[{"end":"2021-11-15","val":12454790,"accn":"0001213900-21-059980","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-16","frame":"CY2021Q4I"}]}}},"us-gaap":{"AccountsPayableAndOtherAccruedLiabilitiesCurrent":{"label":"Accounts Payable and Other Accrued Liabilities, Current","description":"Amount of liabilities incurred to vendors for goods and services received, and accrued liabilities classified as other, payable within one year or the normal operating cycle, if longer.","units":{"USD":[{"end":"2020-12-31","val":9000,"accn":"0001213900-21-059980","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-16","frame":"CY2020Q4I"},{"end":"2021-09-30","val":175000,"accn":"0001213900-21-059980","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-16","frame":"CY2021Q3I"}]}},"AccountsPayableCurrent":{"label":"Accounts Payable, Current","description":"Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).","units":{"USD":[{"end":"2021-09-30","val":12000,"accn":"0001213900-21-059980","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-16","frame":"CY2021Q3I"}]}},"AdditionalPaidInCapital":{"label":"Additional Paid in Capital","description":"Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.","units":{"USD":[{"end":"2020-12-31","val":991000,"accn":"0001213900-21-059980","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-16","frame":"CY2020Q4I"},{"end":"2021-09-30","val":1964000,"accn":"0001213900-21-059980","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-16","frame":"CY2021Q3I"}]}},"Assets":{"label":"Assets","description":"Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.","units":{"USD":[{"end":"2020-12-31","val":323000,"accn":"0001213900-21-059980","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-16","frame":"CY2020Q4I"},{"end":"2021-09-30","val":62000,"accn":"0001213900-21-059980","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-16","frame":"CY2021Q3I"}]}},"AssetsCurrent":{"label":"Assets, Current","description":"Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.","units":{"USD":[{"end":"2020-12-31","val":323000,"accn":"0001213900-21-059980","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-16","frame":"CY2020Q4I"},{"end":"2021-09-30","val":62000,"accn":"0001213900-21-059980","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-16","frame":"CY2021Q3I"}]}},"CashAndCashEquivalentsAtCarryingValue":{"label":"Cash and Cash Equivalents, at Carrying Value","description":"Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.","units":{"USD":[{"end":"2019-12-31","val":50000,"accn":"0001213900-21-059980","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-16","frame":"CY2019Q4I"},{"end":"2020-09-30","val":36000,"accn":"0001213900-21-059980","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-16","frame":"CY2020Q3I"},{"end":"2020-12-31","val":95000,"accn":"0001213900-21-059980","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-16","frame":"CY2020Q4I"},{"end":"2021-09-30","val":37000,"accn":"0001213900-21-059980","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-16","frame":"CY2021Q3I"}]}},"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect":{"label":"Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect","description":"Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.","units":{"USD":[{"start":"2020-01-01","end":"2020-09-30","val":-14000,"accn":"0001213900-21-059980","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-16"},{"start":"2021-01-01","end":"2021-09-30","val":-58000,"accn":"0001213900-21-059980","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-16"}]}},"CommonStockParOrStatedValuePerShare":{"label":"Common Stock, Par or Stated Value Per Share","description":"Face amount or stated value per share of common stock.","units":{"USD/shares":[{"end":"2020-12-31","val":0.001,"accn":"0001213900-21-059980","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-16","frame":"CY2020Q4I"},{"end":"2021-09-30","val":0.001,"accn":"0001213900-21-059980","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-16","frame":"CY2021Q3I"}]}},"CommonStockSharesIssued":{"label":"Common Stock, Shares, Issued","description":"Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.","units":{"shares":[{"end":"2020-12-31","val":21020560,"accn":"0001213900-21-059980","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-16","frame":"CY2020Q4I"},{"end":"2021-09-30","val":21020560,"accn":"0001213900-21-059980","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-16","frame":"CY2021Q3I"}]}},"CommonStockSharesOutstanding":{"label":"Common Stock, Shares, Outstanding","description":"Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.","units":{"shares":[{"end":"2020-12-31","val":9459253,"accn":"0001213900-21-059980","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-16","frame":"CY2020Q4I"},{"end":"2021-09-30","val":12142790,"accn":"0001213900-21-059980","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-16","frame":"CY2021Q3I"}]}},"CommonStockValue":{"label":"Common Stock, Value, Issued","description":"Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.","units":{"USD":[{"end":"2020-12-31","val":9000,"accn":"0001213900-21-059980","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-16","frame":"CY2020Q4I"},{"end":"2021-09-30","val":12000,"accn":"0001213900-21-059980","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-16","frame":"CY2021Q3I"}]}},"EarningsPerShareBasicAndDiluted":{"label":"Earnings Per Share, Basic and Diluted","description":"The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.","units":{"USD/shares":[{"start":"2020-01-01","end":"2020-09-30","val":0.05,"accn":"0001213900-21-059980","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-16"},{"start":"2020-07-01","end":"2020-09-30","val":0.02,"accn":"0001213900-21-059980","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-16","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-09-30","val":0.09,"accn":"0001213900-21-059980","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-16"},{"start":"2021-07-01","end":"2021-09-30","val":0.03,"accn":"0001213900-21-059980","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-16","frame":"CY2021Q3"}]}},"ExcessStockSharesIssued":{"label":"Excess Stock, Shares Issued","description":"Number of excess stock shares of an entity that have been sold or granted to shareholders.","units":{"shares":[{"end":"2021-05-14","val":9459253,"accn":"0001213900-21-059980","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-16","frame":"CY2021Q1I"}]}},"GeneralAndAdministrativeExpense":{"label":"General and Administrative Expense","description":"The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.","units":{"USD":[{"start":"2020-01-01","end":"2020-09-30","val":238000,"accn":"0001213900-21-059980","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-16"},{"start":"2020-07-01","end":"2020-09-30","val":166000,"accn":"0001213900-21-059980","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-16","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-09-30","val":503000,"accn":"0001213900-21-059980","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-16"},{"start":"2021-07-01","end":"2021-09-30","val":257000,"accn":"0001213900-21-059980","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-16","frame":"CY2021Q3"}]}},"IncreaseDecreaseInAccountsPayable":{"label":"Increase (Decrease) in Accounts Payable","description":"The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.","units":{"USD":[{"start":"2020-01-01","end":"2020-09-30","val":42000,"accn":"0001213900-21-059980","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-16"},{"start":"2021-01-01","end":"2021-09-30","val":140000,"accn":"0001213900-21-059980","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-16"}]}},"IncreaseDecreaseInOtherCurrentAssets":{"label":"Increase (Decrease) in Other Current Assets","description":"Amount of increase (decrease) in current assets classified as other.","units":{"USD":[{"start":"2020-01-01","end":"2020-09-30","val":-135000,"accn":"0001213900-21-059980","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-16"},{"start":"2021-01-01","end":"2021-09-30","val":-203000,"accn":"0001213900-21-059980","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-16"}]}},"Investments":{"label":"Investments","description":"Sum of the carrying amounts as of the balance sheet date of all investments.","units":{"USD":[{"end":"2021-08-31","val":950000,"accn":"0001213900-21-059980","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-16","frame":"CY2021Q3I"}]}},"LiabilitiesAndStockholdersEquity":{"label":"Liabilities and Equity","description":"Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.","units":{"USD":[{"end":"2020-12-31","val":323000,"accn":"0001213900-21-059980","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-16","frame":"CY2020Q4I"},{"end":"2021-09-30","val":62000,"accn":"0001213900-21-059980","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-16","frame":"CY2021Q3I"}]}},"LiabilitiesCurrent":{"label":"Liabilities, Current","description":"Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.","units":{"USD":[{"end":"2020-12-31","val":366000,"accn":"0001213900-21-059980","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-16","frame":"CY2020Q4I"},{"end":"2021-09-30","val":187000,"accn":"0001213900-21-059980","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-16","frame":"CY2021Q3I"}]}},"NetCashProvidedByUsedInFinancingActivities":{"label":"Net Cash Provided by (Used in) Financing Activities","description":"Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.","units":{"USD":[{"start":"2020-01-01","end":"2020-09-30","val":297000,"accn":"0001213900-21-059980","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-16"},{"start":"2021-01-01","end":"2021-09-30","val":657000,"accn":"0001213900-21-059980","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-16"}]}},"NetCashProvidedByUsedInOperatingActivities":{"label":"Net Cash Provided by (Used in) Operating Activities","description":"Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.","units":{"USD":[{"start":"2020-01-01","end":"2020-09-30","val":-311000,"accn":"0001213900-21-059980","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-16"},{"start":"2021-01-01","end":"2021-09-30","val":-715000,"accn":"0001213900-21-059980","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-16"}]}},"NetIncomeLoss":{"label":"Net Income (Loss) Attributable to Parent","description":"The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.","units":{"USD":[{"start":"2020-01-01","end":"2020-06-30","val":-245000,"accn":"0001213900-21-059980","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-16"},{"start":"2020-01-01","end":"2020-09-30","val":-488000,"accn":"0001213900-21-059980","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-16"},{"start":"2020-07-01","end":"2020-09-30","val":-243000,"accn":"0001213900-21-059980","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-16","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-06-30","val":-642000,"accn":"0001213900-21-059980","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-16"},{"start":"2021-01-01","end":"2021-09-30","val":-1058000,"accn":"0001213900-21-059980","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-16"},{"start":"2021-07-01","end":"2021-09-30","val":-416000,"accn":"0001213900-21-059980","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-16","frame":"CY2021Q3"}]}},"NoncashMergerRelatedCosts":{"label":"Noncash Merger Related Costs","description":"Amount of expense (income) related to the increase (decrease) in reserve for business combination costs. Includes, but is not limited to, legal, accounting, and other costs incurred to consummate the merger.","units":{"USD":[{"start":"2021-01-01","end":"2021-09-30","val":160000,"accn":"0001213900-21-059980","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-16"}]}},"NonoperatingIncomeExpense":{"label":"Nonoperating Income (Expense)","description":"The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).","units":{"USD":[{"start":"2020-01-01","end":"2020-09-30","val":-9000,"accn":"0001213900-21-059980","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-16"},{"start":"2020-07-01","end":"2020-09-30","val":-8000,"accn":"0001213900-21-059980","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-16","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-09-30","val":-3000,"accn":"0001213900-21-059980","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-16"},{"start":"2021-07-01","end":"2021-09-30","val":2000,"accn":"0001213900-21-059980","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-16","frame":"CY2021Q3"}]}},"OperatingIncomeLoss":{"label":"Operating Income (Loss)","description":"The net result for the period of deducting operating expenses from operating revenues.","units":{"USD":[{"start":"2020-01-01","end":"2020-09-30","val":-479000,"accn":"0001213900-21-059980","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-16"},{"start":"2020-07-01","end":"2020-09-30","val":-235000,"accn":"0001213900-21-059980","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-16","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-09-30","val":-1055000,"accn":"0001213900-21-059980","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-16"},{"start":"2021-07-01","end":"2021-09-30","val":-418000,"accn":"0001213900-21-059980","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-16","frame":"CY2021Q3"}]}},"OtherAssetsCurrent":{"label":"Other Assets, Current","description":"Amount of current assets classified as other.","units":{"USD":[{"end":"2020-12-31","val":228000,"accn":"0001213900-21-059980","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-16","frame":"CY2020Q4I"},{"end":"2021-09-30","val":25000,"accn":"0001213900-21-059980","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-16","frame":"CY2021Q3I"}]}},"PaymentsForMergerRelatedCosts":{"label":"Payments for Merger Related Costs","description":"The amount of cash paid during the reporting period for charges associated with the mergers.","units":{"USD":[{"start":"2021-01-01","end":"2021-09-30","val":370000,"accn":"0001213900-21-059980","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-16"}]}},"PreferredStockParOrStatedValuePerShare":{"label":"Preferred Stock, Par or Stated Value Per Share","description":"Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.","units":{"USD/shares":[{"end":"2020-12-31","val":0.001,"accn":"0001213900-21-059980","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-16","frame":"CY2020Q4I"},{"end":"2021-09-30","val":0.001,"accn":"0001213900-21-059980","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-16","frame":"CY2021Q3I"}]}},"PreferredStockSharesAuthorized":{"label":"Preferred Stock, Shares Authorized","description":"The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.","units":{"shares":[{"end":"2020-12-31","val":500000,"accn":"0001213900-21-059980","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-16","frame":"CY2020Q4I"},{"end":"2021-09-30","val":500000,"accn":"0001213900-21-059980","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-16","frame":"CY2021Q3I"}]}},"ProceedsFromConvertibleDebt":{"label":"Proceeds from Convertible Debt","description":"The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.","units":{"USD":[{"start":"2021-01-01","end":"2021-09-30","val":174000,"accn":"0001213900-21-059980","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-16"}]}},"ProceedsFromDebtNetOfIssuanceCosts":{"label":"Proceeds from Debt, Net of Issuance Costs","description":"The cash inflow from additional borrowings, net of cash paid to third parties in connection with debt origination.","units":{"USD":[{"start":"2021-01-01","end":"2021-09-30","val":52000,"accn":"0001213900-21-059980","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-16"}]}},"ProceedsFromIssuanceOfCommonStock":{"label":"Proceeds from Issuance of Common Stock","description":"The cash inflow from the additional capital contribution to the entity.","units":{"USD":[{"start":"2020-01-01","end":"2020-09-30","val":297000,"accn":"0001213900-21-059980","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-16"},{"start":"2021-01-01","end":"2021-09-30","val":470000,"accn":"0001213900-21-059980","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-16"}]}},"ResearchAndDevelopmentExpense":{"label":"Research and Development Expense","description":"The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.","units":{"USD":[{"start":"2020-01-01","end":"2020-09-30","val":241000,"accn":"0001213900-21-059980","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-16"},{"start":"2020-07-01","end":"2020-09-30","val":69000,"accn":"0001213900-21-059980","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-16","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-09-30","val":552000,"accn":"0001213900-21-059980","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-16"},{"start":"2021-07-01","end":"2021-09-30","val":161000,"accn":"0001213900-21-059980","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-16","frame":"CY2021Q3"}]}},"RetainedEarningsAccumulatedDeficit":{"label":"Retained Earnings (Accumulated Deficit)","description":"The cumulative amount of the reporting entity's undistributed earnings or deficit.","units":{"USD":[{"end":"2020-12-31","val":-1043000,"accn":"0001213900-21-059980","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-16","frame":"CY2020Q4I"},{"end":"2021-09-30","val":-2101000,"accn":"0001213900-21-059980","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-16","frame":"CY2021Q3I"}]}},"SharesIssued":{"label":"Shares, Issued","description":"Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.","units":{"shares":[{"end":"2021-05-14","val":1051028,"accn":"0001213900-21-059980","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-16","frame":"CY2021Q1I"}]}},"ShortTermBorrowings":{"label":"Short-term Debt","description":"Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.","units":{"USD":[{"end":"2020-12-31","val":357000,"accn":"0001213900-21-059980","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-16","frame":"CY2020Q4I"}]}},"StockholdersEquity":{"label":"Stockholders' Equity Attributable to Parent","description":"Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.","units":{"USD":[{"end":"2019-12-31","val":208000,"accn":"0001213900-21-059980","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-16","frame":"CY2019Q4I"},{"end":"2020-06-30","val":-37000,"accn":"0001213900-21-059980","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-16","frame":"CY2020Q2I"},{"end":"2020-09-30","val":-280000,"accn":"0001213900-21-059980","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-16","frame":"CY2020Q3I"},{"end":"2020-12-31","val":-43000,"accn":"0001213900-21-059980","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-16","frame":"CY2020Q4I"},{"end":"2021-06-30","val":191000,"accn":"0001213900-21-059980","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-16","frame":"CY2021Q2I"},{"end":"2021-09-30","val":-125000,"accn":"0001213900-21-059980","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-16","frame":"CY2021Q3I"}]}},"StockIssuedDuringPeriodSharesNewIssues":{"label":"Stock Issued During Period, Shares, New Issues","description":"Number of new stock issued during the period.","units":{"shares":[{"start":"2021-05-01","end":"2021-05-14","val":9459253,"accn":"0001213900-21-059980","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-16","frame":"CY2021Q1I"},{"start":"2021-07-01","end":"2021-07-31","val":90012,"accn":"0001213900-21-059980","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-16","frame":"CY2021Q2I"},{"start":"2021-01-01","end":"2021-09-30","val":1542497,"accn":"0001213900-21-059980","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-16"}]}},"StockIssuedDuringPeriodValueNewIssues":{"label":"Stock Issued During Period, Value, New Issues","description":"Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.","units":{"USD":[{"start":"2021-01-01","end":"2021-06-30","val":370000,"accn":"0001213900-21-059980","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-16"},{"start":"2021-07-01","end":"2021-09-30","val":100000,"accn":"0001213900-21-059980","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-16","frame":"CY2021Q3"}]}},"StockIssuedDuringPeriodValueOther":{"label":"Stock Issued During Period, Value, Other","description":"Value of shares of stock issued attributable to transactions classified as other.","units":{"USD":[{"start":"2021-01-01","end":"2021-06-30","val":506000,"accn":"0001213900-21-059980","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-16"}]}},"TemporaryEquityStockIssuedDuringPeriodValueNewIssues":{"label":"Temporary Equity, Stock Issued During Period, Value, New Issues","description":"Value of new stock classified as temporary equity issued during the period.","units":{"USD":[{"start":"2021-07-01","end":"2021-07-31","val":100000,"accn":"0001213900-21-059980","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-16","frame":"CY2021Q2I"},{"start":"2021-01-01","end":"2021-09-30","val":478000,"accn":"0001213900-21-059980","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-16"}]}},"WeightedAverageNumberOfShareOutstandingBasicAndDiluted":{"label":"Weighted Average Number of Shares Outstanding, Basic and Diluted","description":"Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).","units":{"shares":[{"start":"2020-01-01","end":"2020-09-30","val":9459253,"accn":"0001213900-21-059980","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-16"},{"start":"2020-07-01","end":"2020-09-30","val":9459253,"accn":"0001213900-21-059980","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-16","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-09-30","val":10811014,"accn":"0001213900-21-059980","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-16"},{"start":"2021-07-01","end":"2021-09-30","val":12131663,"accn":"0001213900-21-059980","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-16","frame":"CY2021Q3"}]}}}}}